Search results
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoJanuary 2022, AVEO Oncology and German company Merck KGaA signed a clinical trial partnership and...
Ovarian cancer patient hails treatment as a 'lifeline'
BBC News· 4 days agoChristine Campbell, from Dundonald was diagnosed with stage-four high-grade ovarian cancer three...
Lung cancer: Why non-smokers don't respond to treatments
Medical News Today· 2 days agoResearchers report that people who have never smoked are less likely to respond to standard...
Terry Whitt Bailey: Reforming federal program gives cancer patients glimmer of hope - The Republic...
The Republic News· 2 hours agoHere in Indiana, 53 of the 92 counties have a shortage of primary health providers. For cancer patients, this means they not only face the daily battle against a life-threatening ...
Kate Middleton Shares First New Photo of Herself Since Cancer Reveal
Entertainment Tonight· 13 hours agoKate Middleton gave her followers an update Friday on social media, sharing the first new photo...
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks via Yahoo Finance· 14 hours agoShattuck (STTK) will now focus on higher-risk myelodysplastic syndromes and TP53 mutant acute...
Nano-immunotherapy developed to improve lung cancer treatment
Medical Xpress· 14 hours agoThe team showed promising results for the new therapy in cancer cells in the lab and in mouse lung tumor models, with potential applications for improving care and outcomes ...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 18 hours agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 2 days agoThe Endocyte acquisition brought a PSMA-targeted agent that would prove to be a real game-changer — both for patients with certain difficult-to-treat...
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks· 1 day agoSL-172154 is an investigational agonist redirected checkpoint fusion protein, designed to simultaneously inhibit the CD47/SIRPα checkpoint interaction and activate the CD40 costimulatory receptor ...